Date/Time:Thursday, June 13 (6 pm) - Saturday, June 15, 2024 (5 pm) BST Location:The Excel CentreRoyal Victoria Dock, 1 Western GatewayLondon E16 1XL, United Kingdom YINGCHI Booth: 301 Detail Information:https://www.clinicaltmssociety.org/events/365/12700/2024-annual-meeting The Clinical TMS Society's 12th Annual Meeting is coming soon. Over the years, the Clinical TMS Society's annual meeting has been providing a unique opportunity to... Read more
Florence, Italy, March 28, 2024 – Today, the Hanix group has announced its total acquisition of the shares of EB Neuro S.p.A. EB Neuro S.p.A. is an Italian leading manufacturer of medical devices in the neurological field with equipment for EEG, EMG, TMS and Neuronavigation. It is the first company in the world to have... Read more
Date/Time:Tuesday, March 5th, 2024 - Wednesday, March 6th, 2024 Location:Shenzhen, Guangdong, China In order to expend the distributors' knowledge of TMS and more understanding of YINGCHI TMS device, so as to deal with and solve related problems more effectively, and to consolidate the friendly cooperative relationship with our partners, our company held the 2024 Asia Business Partner... Read more
Date:Monday, Nov. 13 - Thursday, Nov. 16, 2023 CET Location:Düsseldorf, Germany Official Website:https://www.medica-tradefair.com/ YINGCHI Booth:9C54 With over 5,000 exhibitors from 66 countries and more than 81,000 visitors from all over the world, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. As an old friend, YINGCHI will once again participate in MEDICA 2023.... Read more
In September 2023, YINGCHI M-Ultimate TMS received FDA approval for the treatment of major depressive disorder in adult patients, marking a significant milestone in the company's endeavor to provide safe and effective medical solutions. Moreover, YINGCHI M-Ultimate TMS is not only limited to clinical applications; it is also playing an essential role in advancing clinical... Read more
We are glad to announce that YINGCHI M-Ultimate transcranial magnetic stimulator has already gained FDA approval this September . The M-Ultimate TMS is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. Depression is a widespread and debilitating mental health condition,... Read more
